Why Polynucleotides are Replacing Traditional Soft Fillers

We are seeing a significant shift in patient demand away from traditional hyaluronic acid fillers toward regenerative biostimulators like polynucleotides. As operators, we recognize that while fillers provide immediate volume, they often lead to long-term lymphatic obstruction or a heavy appearance in the periorbital area. By utilizing salmon DNA-derived fragments, we trigger fibroblast stimulation and collagen synthesis without the risks of tyndall effect or migration. We have found these injectable treatments particularly effective for thinning skin around the lower eyelids where traditional fillers frequently fail. Integrating polynucleotides into our service menus allows us to address structural skin health rather than just masking volume loss. This approach reduces our reliance on hyaluronidase corrections and builds long-term patient trust through natural-looking results. Success in this category requires precise intradermal injection techniques, but the clinical payoff in skin elasticity and hydration far exceeds what we achieved with basic cross-linked gels.